Forums: General Discussion
Melanie,
I was recently at a meeting with the FDA and the reviewer asked for Amendment 1. However, it may depend on the reviewer so it is always a good idea to make this part of the discussion with the FDA when you are submitting data to them.
David
Dear all,
I just wanted to know if the FDA is OK to receive data with amendment 1 now or if they are still based on SDTM 3.1.2 ?
Thanks for your help !
Melanie